SRPT vs TASK
Sarepta Therapeutics Inc (SRPT) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
SRPT currently screens at market cap $2.34B. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the SRPT and TASK stock pages for the full models.
Not investment advice.